{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:45:34Z","timestamp":1788864334659,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hyperparathyroidism occurs commonly in the dialysis population, and surgical parathyroidectomy (PTx) is often required when medical therapy to suppress parathyroid hormone (PTH) fails. Surgical techniques include subtotal and total PTx, with or without auto-transplantation, with the choice of procedure generally determined by surgical preference rather than patient-related factors. The aim of this study was to compare outcomes of these surgical procedures, focusing on post-operative utilization of hospital resources, and biochemical and patient-level outcomes over the year following surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective observational study included dialysis patients undergoing subtotal or total PTx (\u00b1 auto-transplant) over 9-years at three tertiary-level hospitals in Sydney, Australia. Laboratory and patient-level-outcomes were compared immediately post-operatively and at one, three and 12-months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 64 dialysis patients undergoing PTx, 60.9% were male and the mean dialysis vintage was 5.9 (4.2) years. Total PTx was performed in 51, 46 with auto-transplantation, and subtotal PTx in 13. Patient characteristics were similar at baseline. Compared to subtotal PTx, total PTx resulted in lower post-operative calcium values (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), higher intravenous calcium requirements (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) and more frequent admission to intensive care (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). After total PTx, the daily calcium and calcitriol pill burden at discharge was higher (median 25 (IQR 20\u201340) vs. 18 (IQR 6\u201326), <jats:italic>p<\/jats:italic>\u2009=\u20090.04) and at 3-months (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), and 23.5% of patients were readmitted for calcium management (<jats:italic>p<\/jats:italic>\u2009=\u20090.05). At 12-months, more patients undergoing subtotal PTx had PTH values above guideline recommendations (42.9% vs. 9.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02), pill burdens did not differ, and bone mineral density increased in both groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Total PTx requires greater post-operative resources but is associated with lower PTH values at 12-months, whereas subtotal PTx is associated with a lower pill burden but increased hyperparathyroidism recurrence. A tailored strategy is suggested, matching the surgical approach to patient needs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04335-5","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:42:10Z","timestamp":1752680530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subtotal versus total parathyroidectomy: retrospective patient-centric outcomes in a chronic dialysis population"],"prefix":"10.1186","volume":"26","author":[{"given":"Raymond","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Vucak-Dzumhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grahame J.","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"4335_CR1","volume-title":"Hyperparathyroidism in chronic kidney disease","author":"TB Dr\u00fceke","year":"2000","unstructured":"Dr\u00fceke TB. Hyperparathyroidism in Chronic Kidney Disease. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2024, MDText.com, Inc.; 2000"},{"issue":"4","key":"4335_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00223-020-00779-z","volume":"108","author":"A Pimentel","year":"2021","unstructured":"Pimentel A, Ure\u00f1a-Torres P, Bover J, Luis Fernandez-Mart\u00edn J, Cohen-Solal M. Bone fragility fractures in CKD patients. Calcif Tissue Int. 2021;108(4):539\u201350.","journal-title":"Calcif Tissue Int"},{"key":"4335_CR3","doi-asserted-by":"crossref","unstructured":"KDIGO. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2011. 2017. (2017;7(1):1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"4335_CR4","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1046\/j.1523-1755.61.s80.27.x","volume":"61","author":"ALM De Francisco","year":"2002","unstructured":"De Francisco ALM, Fresnedo GF, Rodrigo E, Pi\u00f1era, Amado JA, Arias M. Parathyroidectomy in dialysis patients. Kidney Int. 2002;61:S161\u20136.","journal-title":"Kidney Int"},{"key":"4335_CR5","doi-asserted-by":"publisher","first-page":"1191914","DOI":"10.3389\/fendo.2023.1191914","volume":"14","author":"C Iorga","year":"2023","unstructured":"Iorga C, Iorga CR, Andreiana I, Bengulescu I, Constantin T, Strambu V. Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease. Front Endocrinol (Lausanne). 2023;14:1191914.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"4335_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/archsurg.143.8.756","volume":"143","author":"N Rayes","year":"2008","unstructured":"Rayes N, Seehofer D, Schindler R, Reinke P, Kahl A, Ulrich F, et al. Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg. 2008;143(8):756\u201361; discussion 61.","journal-title":"Arch Surg"},{"issue":"1","key":"4335_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.surg.2018.04.076","volume":"165","author":"E Isaksson","year":"2019","unstructured":"Isaksson E, Ivarsson K, Akaberi S, Muth A, Pr\u00fctz K-G, Clyne N, et al. Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery. 2019;165(1):142\u201350.","journal-title":"Surgery"},{"issue":"5","key":"4335_CR8","doi-asserted-by":"publisher","first-page":"e15752","DOI":"10.1016\/j.heliyon.2023.e15752","volume":"9","author":"J Zhu","year":"2023","unstructured":"Zhu J, Wu Y, Huang T, Jiang G, Yang Z. Efficacy and safety of total parathyroidectomy with autotransplantation vs. subtotal parathyroidectomy for secondary hyperparathyroidism: A retrospective study. Heliyon. 2023;9(5):e15752.","journal-title":"Heliyon"},{"key":"4335_CR9","doi-asserted-by":"crossref","unstructured":"Zmijewski PV, Staloff JA, Wozniak MJ, Mazzaglia PJ. Subtotal parathyroidectomy vs total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in dialysis patients: Short- and long-term outcomes. J Am Coll Surgeons. 2019;228(6).","DOI":"10.1016\/j.jamcollsurg.2019.01.019"},{"key":"4335_CR10","doi-asserted-by":"crossref","unstructured":"Hernandes FR, Canziani ME, Barreto FC, Santos RO, Moreira VM, Rochitte CE, Carvalho AB. The shift from high to low turnover bone disease after parathyroidectomy is associated with the progression of vascular calcification in hemodialysis patients: A 12-month follow-up study. PLoS One. 2017;12(4):e0174811.","DOI":"10.1371\/journal.pone.0174811"},{"key":"4335_CR11","doi-asserted-by":"crossref","unstructured":"Albuck AL, Landau MB, LaForteza AC, Hussein M, Issa PP, McCarthy C, et al. Subtotal versus total parathyroidectomy for the management of tertiary hyperparathyroidism: A systematic literature review and meta-analysis of optimal surgical modality. Am J Intellect Dev Disabil Surgeon\u2122. 2024;00031348241290615.","DOI":"10.1177\/00031348241290615"},{"key":"4335_CR12","doi-asserted-by":"crossref","unstructured":"Chen J, Jia X, Kong X, Wang Z, Cui M, Xu D. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis. Nephrol (Carlton). 2017;22(5):388\u201396.","DOI":"10.1111\/nep.12801"},{"key":"4335_CR13","doi-asserted-by":"crossref","unstructured":"Lo CY. Parathyroid autotransplantation during thyroidectomy. ANZ J Surg. 2002;72(12):902\u201307.","DOI":"10.1046\/j.1445-2197.2002.02580.x"},{"issue":"4","key":"4335_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/XCS.0000000000000539","volume":"236","author":"R Wang","year":"2023","unstructured":"Wang R, Disharoon M, Frazier R, Xie R, Moses C, Gillis A, et al. Less is more: Parathyroidectomy and association with postoperative hypocalcemia in dialysis patients. J Am Coll Surg. 2023;236(4):639\u201345.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"4335_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00268-008-9787-2","volume":"33","author":"SP Cheng","year":"2009","unstructured":"Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL. Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg. 2009;33(1):72\u201379.","journal-title":"World J Surg"},{"issue":"6","key":"4335_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2215\/CJN.00290109","volume":"4","author":"Y-W Chiu","year":"2009","unstructured":"Chiu Y-W, Teitelbaum I, Misra M, de Leon EM, Adzize T, Burden MRP. Adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Of Nephrol. 2009;4(6):1089\u201396.","journal-title":"Clin J Am Soc Of Nephrol"},{"issue":"5","key":"4335_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.amjsurg.2017.07.018","volume":"214","author":"K Anderson Jr","year":"2017","unstructured":"Anderson K Jr, Ruel E, Adam MA, Thomas S, Youngwirth L, Stang MT, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. Am J Surg. 2017;214(5):914\u201319.","journal-title":"Am J Surg"},{"issue":"2","key":"4335_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00268-018-4823-3","volume":"43","author":"JD Lee","year":"2019","unstructured":"Lee JD, Kuo EJ, Du L, Yeh MW, Livhits MJ. Risk factors for readmission after parathyroidectomy for renal hyperparathyroidism. World J Surg. 2019;43(2):534\u201339.","journal-title":"World J Surg"},{"issue":"10","key":"4335_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.metabol.2013.05.007","volume":"62","author":"MH Gannag\u00e9-Yared","year":"2013","unstructured":"Gannag\u00e9-Yared MH, Far\u00e8s C, Ibrahim T, Rahal ZA, Elias M, Chelala D. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients. Metabolism. 2013;62(10):1416\u201322.","journal-title":"Metabolism"},{"issue":"8","key":"4335_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.21037\/gs-23-54","volume":"12","author":"KA Black","year":"2023","unstructured":"Black KA, Galata G, Schulte K-M, Hubbard JG. Comparing subtotal parathyroidectomy and total parathyroidectomy with autotransplantation in renal transplant recipients. Gland Surg. 2023;12(8):1060\u201366.","journal-title":"Gland Surg"},{"issue":"1","key":"4335_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000045533","volume":"84","author":"K Tsuchihashi","year":"2000","unstructured":"Tsuchihashi K, Takizawa H, Torii T, Ikeda R, Nakahara N, Yuda S, et al. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: Possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease. Nephron. 2000;84(1):13\u201320.","journal-title":"Nephron"},{"issue":"3","key":"4335_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4335_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/nep.13986","volume":"27","author":"S Saeseow","year":"2022","unstructured":"Saeseow S, Vantanasiri K, Suvikapakornkul R, Sukarayothin T, Apirakkittikul N, Disthabanchong S. Parathyroidectomy is associated with slow progression of vascular calcification in maintenance haemodialysis patients: A propensity score-matched case-control study. Nephrol (Carlton). 2022;27(4):355\u201362.","journal-title":"Nephrol (Carlton)"},{"issue":"1","key":"4335_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.asjsur.2018.04.001","volume":"42","author":"Z Gao","year":"2019","unstructured":"Gao Z, Li X, Miao J, Lun L. Impacts of parathyroidectomy on calcium and phosphorus metabolism disorder, arterial calcification and arterial stiffness in haemodialysis patients. Asian J Surg. 2019;42(1):6\u201310.","journal-title":"Asian J Surg"},{"issue":"2","key":"4335_CR25","doi-asserted-by":"publisher","first-page":"2402515","DOI":"10.1080\/0886022X.2024.2402515","volume":"46","author":"B Chen","year":"2024","unstructured":"Chen B, Fang Q, Tao Y, Peng S, Deng S, Yuan Y, et al. Factors associated with dysfunction of autogenous arteriovenous fistula in patients with secondary hyperparathyroidism after parathyroidectomy. Ren Fail. 2024;46(2):2402515.","journal-title":"Ren Fail"},{"issue":"11","key":"4335_CR26","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1210\/jcem.83.11.5249","volume":"83","author":"M Abdelhadi","year":"1998","unstructured":"Abdelhadi M, Nordenstr\u00f6m J. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab. 1998;83(11):3845\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4335_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.ajkd.2023.10.007","volume":"83","author":"A-M Wang","year":"2024","unstructured":"Wang A-M, Tang T-K, Yau Y-Y, Lo WK. Impact of parathyroidectomy versus oral cinacalcet on bone mineral density in patients on peritoneal dialysis with advanced secondary hyperparathyroidism: The PROCEED Pilot randomized trial. Am J Kidney Dis. 2024;83(4):456\u201366.e1.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4335_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12882-020-02168-y","volume":"21","author":"R Lin","year":"2020","unstructured":"Lin R, Vucak-Dzumhur M, Elder GJ. Changes to bone mineral density, the trabecular bone score and hip structural analysis following parathyroidectomy: A case report. BMC Nephrol. 2020;21(1):513.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04335-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04335-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:12:41Z","timestamp":1757247161000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04335-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04335-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols in the study were approved by the Nepean Blue Mountains Local Health District (NBMLHD) Low and Negligible Risk Subcommittee and ratified by the NBMLHD Human Research Ethics Committee (HREC 2025\/ETH000321) in accordance with National Health and Medical Research Council\u2019s \u201cNational Statement on Ethical Conduct in Human Research\u201d. The ethical process is consistent with the Declaration of Helsinki. The study was reviewed as \u2018Low or negligible risk\u2019 and a waiver of usual requirement of consent for the use of re-identifiable information was granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}